WO2001010340A1 - Corkscrew reinforced left ventricle to coronary artery channel - Google Patents

Corkscrew reinforced left ventricle to coronary artery channel Download PDF

Info

Publication number
WO2001010340A1
WO2001010340A1 PCT/US2000/021120 US0021120W WO0110340A1 WO 2001010340 A1 WO2001010340 A1 WO 2001010340A1 US 0021120 W US0021120 W US 0021120W WO 0110340 A1 WO0110340 A1 WO 0110340A1
Authority
WO
WIPO (PCT)
Prior art keywords
channel
coil
coronary artery
corkscrew
left ventricle
Prior art date
Application number
PCT/US2000/021120
Other languages
French (fr)
Inventor
Patrick Cahalan
Original Assignee
Percardia, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Percardia, Inc. filed Critical Percardia, Inc.
Priority to AU63972/00A priority Critical patent/AU6397200A/en
Priority to US10/048,408 priority patent/US7033372B1/en
Publication of WO2001010340A1 publication Critical patent/WO2001010340A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2493Transmyocardial revascularisation [TMR] devices

Abstract

A coil is screwed into the heart wall HW between the left ventricle and coronary artery, followed by forming of a channel with laser, plasma, electrical, or mechanical device therethrough.

Description

CORKSCREW REINFORCED LEFT VENTRICLE TO CORONARY ARTERY
CHANNEL
Background of the Invention Field of the Invention
This invention relates to method and apparatus for forming a channel to allow communication of fluids from one portion of a patient's body to another, and more particularly, to a device that can communicate blood between the left ventricle and coronary arteries or veins. Description of the Related Art
Currently there exists a shunting concept that establishes a passage from the left ventricle directly to the coronary artery by the placement of a stent or hollow tube in a channel formed therethrough. Other designs also suggested that it might be possible to have a stent-less channel (see U.S. Patent No. 5,662,124). Both designs have to deal with problems arising from the contraction and multidimensional movements of the heart wall in relation to the device. For a straight hollow tube the movement may create irritation between the tissue and the metal interface that may lead to a chronic inflammatory response, and maybe even to dislodgement of the tube. For a collapsible or expandable "wire" stent the constant movement can lead to fracture from cyclic fatigue (this has been documented in vivo humans - by Stent Medtronic). With respect to blood compatibility a solid tube presents maximum foreign surface to the blood of materials that are all relatively thrombogenic. While a wire or open stent design has less surface area exposed to blood, the profile of the stent in the flow field is less optimal and requires optimal placement.
Summary of the Invention
What is primarily needed is a device that can control the shape of the open channel between the left ventricle and coronary artery, and can withstand long and continuous complex movement without causing irritation, dislodgement. or fracture. An alternative approach to spikes, and stents. is the use of a screw in coil. The design of such a coil would be much like that of a corkscrew. This same design has been used on implantable pacemaker leads for years to anchor the electrode tips into the endocardium of the heart. This design yields very high stability in terms of pull out force and survival against mechanical dislodgement. It is also well tolerated without chronic inflammatory responses. Another advantage is in placement of the device, as it can be removed with ease and without significant tissue trauma should the initial placement attempt be less than optimal.
Brief Description of the Drawings
FIGURE 1 illustrates a partial cross-sectional view of a coil screwed into the heart wall between the left ventricle and coronary artery.
FIGURE 2 illustrates a partial cross-sectional view of a channel formed through the coil of FIGURE 1.
Detailed Description of the Preferred Embodiment
FIGURES 1 and 2 roughly show the preferred design, which would comprise first screwing in a coil 10 into the heart wall HW between the left ventricle LV and coronary artery CA (FIGURE 1), and then followed by forming of a channel 12 by, for example, laser, plasma, electrical, or mechanical device (FIGURE 2). At this time it would be preferred to use the plasma ablation technique as the diameter of the channel can be controlled with considerable accuracy at the dimensions one would want, and also the asymmetry can be controlled.
In one embodiment, the corkscrew or coil 10 may be configured to have a desired pitch and spacing so that insertion of the coil 10 into the heart wall does not puncture through the coronary artery CA. This is accomplished by choosing an entry point for the coil 10 adjacent the coronary artery, and screwing the coil 10 into the heart wall such that the coronary artery is positioned in between the turns of the coil as the coil is inserted. In this embodiment, the spacing between the turns of the coil is greater than the diameter of the coronary artery.
Up until now it has been suggested that blood exposure to non endothelialized tissue surfaces would be a problem for a formed, stentless channel. In reality the challenge of the denatured proteins on the surface of a formed channel is certainly no more than that of a metal surface of a tube or stent concept.
It is further envisioned that the channel formed would be optimal for "paving" with a biocompatible polymer such as a PEG macromer (Focal of MA), and this could be a rapid and catheter-based method of in situ modification of the channel to improve blood compatibility .
It is also conceivable that the "corkscrew" can be placed on the distal tip of a catheter - and also serves as a guide for the subsequent forming device to make the channel. Electrical circuits can be designed to operate within defined distances from the corkscrew, and can control the forming device that requires energy sources.
An additional advantage of the corkscrew is that a slight projection into the ventricle would not create dead spots for blood pooling like that of a hollow tube. It also would not be subject to rapid over insertion as is the case with puncture like devices.
Finally the corkscrew is not actually inside the channel and therefore presents no problems of profile and placement, as would be the case with an expanding stent design. The latter variable has been thought to be the most critical parameter in intravascular stent use.
It will be appreciated that although the above embodiments have been described as being used between the coronary artery and left ventricle, the methods and apparatus described above can be used between any heart chamber and blood vessel, or through an)' other body tissue between two body lumens in which a channel of blood is desired to be formed.
The embodiments illustrated and described above are provided merely as examples of certain preferred embodiments of the present invention. Various changes and modifications can be made from the embodiments presented herein by those skilled in the art without departure from the spirit and scope of the invention, as defined by the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A method for forming a channel between a first body lumen and a second body- lumen through body tissue, comprising: screwing a coil into the body tissue between the first and second body lumens; and forming a channel through the coil.
2. The method of Claim 1, wherein the channel is formed using a device selected from the group consisting of a laser, plasma, an electrical device and a mechanical device.
3. The method of Claim 1 , wherein the first body lumen is a heart chamber, the second body lumen is a coronary artery or vein, and the body tissue is a heart wall.
4. A reinforced channel between a heart chamber and a blood vessel, comprising: a coil extending through the heart wall between the heart chamber and blood vessel; and a channel through the coil.
5. The reinforced channel of Claim 4, wherein the channel through the coil is formed by ablation.
6. The reinforced channel of Claim 4, wherein the coil does not contact the channel.
PCT/US2000/021120 1999-08-04 2000-08-03 Corkscrew reinforced left ventricle to coronary artery channel WO2001010340A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU63972/00A AU6397200A (en) 1999-08-04 2000-08-03 Corkscrew reinforced left ventricle to coronary artery channel
US10/048,408 US7033372B1 (en) 1999-08-04 2000-08-03 Corkscrew reinforced left ventricle to coronary artery channel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14721099P 1999-08-04 1999-08-04
US60/147,210 1999-08-04

Publications (1)

Publication Number Publication Date
WO2001010340A1 true WO2001010340A1 (en) 2001-02-15

Family

ID=22520671

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/021120 WO2001010340A1 (en) 1999-08-04 2000-08-03 Corkscrew reinforced left ventricle to coronary artery channel

Country Status (2)

Country Link
AU (1) AU6397200A (en)
WO (1) WO2001010340A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662124A (en) 1996-06-19 1997-09-02 Wilk Patent Development Corp. Coronary artery by-pass method
US5878751A (en) * 1996-03-04 1999-03-09 Myocardial Stents, Inc. Method for trans myocardial revascularization (TMR)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5878751A (en) * 1996-03-04 1999-03-09 Myocardial Stents, Inc. Method for trans myocardial revascularization (TMR)
US5662124A (en) 1996-06-19 1997-09-02 Wilk Patent Development Corp. Coronary artery by-pass method

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US7736327B2 (en) 1998-09-10 2010-06-15 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8216174B2 (en) 1998-09-10 2012-07-10 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8597226B2 (en) 1998-09-10 2013-12-03 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system

Also Published As

Publication number Publication date
AU6397200A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
US7033372B1 (en) Corkscrew reinforced left ventricle to coronary artery channel
US6129750A (en) Fixation mechanism for a coronary venous pacing lead
US6385492B1 (en) Probe implantable in the coronary venus system for stimulating the left heart
US7041097B1 (en) System and method for accessing the coronary sinus
US8036757B2 (en) Pacing lead and method for pacing in the pericardial space
US5935119A (en) Perfusion structure
US9345858B2 (en) Catheters, systems and methods for percutaneous in situ arterio-venous bypass
KR102262007B1 (en) Methods and devices for puncturing tissue
US9138228B2 (en) Vascular conduit device and system for implanting
US6887192B1 (en) Heart support to prevent ventricular remodeling
EP1117457B1 (en) Transthoracic drug delivery device
US6248112B1 (en) Implant delivery system
US7765014B2 (en) Apparatus and methods for delivering transvenous leads
JP5108876B2 (en) Cardiac lead assembly having a pluggable stiffening structure for fixation
US20170340316A1 (en) Interventional medical device retrieval
US20070083168A1 (en) Transmembrane access systems and methods
US20040010281A1 (en) Method and device for inserting leads into coronary veins
WO2018008019A2 (en) Apparatus for delivering electrical signals to the heart
US7232421B1 (en) Agent delivery systems
US20210068681A1 (en) Implantable medical sensor and fixation assembly
JP7357383B2 (en) Line device for guiding blood flow in a cardiac assist system, cardiac assist system using the same, and method for manufacturing and assembling the same
WO2000069504A9 (en) Agent delivery systems
WO2001010340A1 (en) Corkscrew reinforced left ventricle to coronary artery channel
US20180228538A1 (en) Cutting system and method of tissue cutting for medical treatment
JP2002136599A (en) Method and apparatus for delivering therapeutic agent to heart

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10048408

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP